Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Tanner

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Annals of Internal Medicine|August 1, 2022
In diabetes, some statins reduce non-HDL-C better than others vs. placeboMichael Tanner
Annals of Internal Medicine|November 16, 2011
ACP Journal Club. Review: pregabalin and other drugs reduce pain in patients with painful diabetic neuropathyMichael Tanner
Annals of Internal Medicine|May 19, 2015
ACP Journal Club. Review: In patients with mild hypertension and no CV disease, BP-lowering drugs reduce stroke and mortalityMichael Tanner
The Hastings Center Report|November 10, 2006
The wrong road to reformMichael Tanner
Annals of Internal Medicine|September 16, 2015
Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetesMichael Tanner
Annals of Internal Medicine|April 4, 2022
Antihypertensive drugs reduced risk for new-onset type 2 diabetes; effect varies by antihypertensive classMichael Tanner
Annals of Internal Medicine|April 17, 2013
ACP Journal Club: metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CADMichael Tanner
Annals of Internal Medicine|March 6, 2023
In adults with delirium in the ICU, haloperidol did not increase number of days alive out of the hospital at 90 dMichael Tanner
U.S. News & World Report|August 19, 2009
Not enough care to go aroundMichael Tanner
Annals of Internal Medicine|April 21, 2020
In screen-detected type 2 diabetes, intensive therapy did not differ from usual care for CV events at 10 yearsMichael Tanner
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Annals of Internal Medicine|August 1, 2022
In diabetes, some statins reduce non-HDL-C better than others vs. placeboMichael Tanner
Annals of Internal Medicine|November 16, 2011
ACP Journal Club. Review: pregabalin and other drugs reduce pain in patients with painful diabetic neuropathyMichael Tanner
Annals of Internal Medicine|May 19, 2015
ACP Journal Club. Review: In patients with mild hypertension and no CV disease, BP-lowering drugs reduce stroke and mortalityMichael Tanner
The Hastings Center Report|November 10, 2006
The wrong road to reformMichael Tanner
Annals of Internal Medicine|September 16, 2015
Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetesMichael Tanner
Annals of Internal Medicine|April 4, 2022
Antihypertensive drugs reduced risk for new-onset type 2 diabetes; effect varies by antihypertensive classMichael Tanner
Annals of Internal Medicine|April 17, 2013
ACP Journal Club: metformin reduced CV events compared with glipizide in patients with type 2 diabetes and CADMichael Tanner
Annals of Internal Medicine|March 6, 2023
In adults with delirium in the ICU, haloperidol did not increase number of days alive out of the hospital at 90 dMichael Tanner
U.S. News & World Report|August 19, 2009
Not enough care to go aroundMichael Tanner
Annals of Internal Medicine|April 21, 2020
In screen-detected type 2 diabetes, intensive therapy did not differ from usual care for CV events at 10 yearsMichael Tanner
Pageof 6